Air Sampling for Fungus around Hospitalized Patients with Coronavirus Disease 2019

The risk of developing coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) depends on factors related to the host, virus, and treatment. However, many hospitals have modified their existing rooms and adjusted airflow to protect healthcare workers from aerosolization, which...

Full description

Bibliographic Details
Main Authors: Chen, Y.-C (Author), Kuo, S.-F (Author), Lee, C.-H (Author), Lin, Y.-S (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 01998nam a2200217Ia 4500
001 10.3390-jof8070692
008 220718s2022 CNT 000 0 und d
020 |a 2309608X (ISSN) 
245 1 0 |a Air Sampling for Fungus around Hospitalized Patients with Coronavirus Disease 2019 
260 0 |b MDPI  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.3390/jof8070692 
520 3 |a The risk of developing coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) depends on factors related to the host, virus, and treatment. However, many hospitals have modified their existing rooms and adjusted airflow to protect healthcare workers from aerosolization, which may increase the risk of Aspergillus exposure. This study aimed to quantitatively investigate airborne fungal levels in negative and slightly negative pressure rooms for COVID-19 patients. The air in neutral pressure rooms in ordinary wards and a liver intensive care unit with high-efficiency particulate air filter was also assessed for comparison. We found the highest airborne fungal burden in recently renovated slightly negative air pressure rooms, and a higher airborne fungal concentration in both areas used to treat COVID-19 patients. The result provided evidence of the potential environmental risk of CAPA by quantitative microbiologic air sampling, which was scarcely addressed in the literature. Enhancing environmental infection control measures to minimize exposure to fungal spores should be considered. However, the clinical implications of a periodic basis to determine indoor airborne fungal levels and further air sterilization in these areas remain to be defined. © 2022 by the authors. Licensee MDPI, Basel, Switzerland. 
650 0 4 |a air sampling 
650 0 4 |a COVID-19 
650 0 4 |a fungus 
650 0 4 |a invasive aspergillosis 
700 1 |a Chen, Y.-C.  |e author 
700 1 |a Kuo, S.-F.  |e author 
700 1 |a Lee, C.-H.  |e author 
700 1 |a Lin, Y.-S.  |e author 
773 |t Journal of Fungi